Indoco Remedies on Tuesday said Teva Pharmaceuticals has launched Brinzolamide ophthalmic suspension used in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma in the United States.

The product, which is a generic version of Azopt ophthalmic suspension, is developed and manufactured by the Mumbai-based drug firm at its Goa facility for Teva.